Myriad Genetics (MYGN) Plunges 1.88% After Guggenheim Downgrade

Generado por agente de IAAinvest Movers Radar
miércoles, 23 de abril de 2025, 6:26 pm ET1 min de lectura
MYGN--

Myriad Genetics (MYGN) shares fell 1.88% today, reaching their lowest level since September 1998, with an intraday decline of 2.15%.

Guggenheim recently downgraded Myriad GeneticsMYGN-- from a "buy" rating to a "neutral" rating in a research report released on April 11, 2025. This change in rating is likely to have contributed to the recent decline in the company's stock price. The downgrade suggests that analysts at Guggenheim may have concerns about the company's future prospects or its ability to meet market expectations.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios